BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Y, De Keersmaecker H, Braeckmans K, De Smedt S, Cani PD, Préat V, Beloqui A. Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment. Biomaterials 2020;255:120209. [PMID: 32580098 DOI: 10.1016/j.biomaterials.2020.120209] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Zhou R, Wang Y, Zhang Y, Yu J, Gu Z. Recent Advances in Oral and Transdermal Protein Delivery Systems. Angew Chem Int Ed Engl 2022;:e202214795. [PMID: 36478123 DOI: 10.1002/anie.202214795] [Reference Citation Analysis]
2 Zhang Y, Wang Y, Li X, Nie D, Liu C, Gan Y. Ligand-modified nanocarriers for oral drug delivery: Challenges, rational design, and applications. J Control Release 2022;352:813-32. [PMID: 36368493 DOI: 10.1016/j.jconrel.2022.11.010] [Reference Citation Analysis]
3 Ibnat N, Zaman R, Uddin MB, Chowdhury E, Lee CY. Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats. World J Diabetes 2022; 13(8): 613-621 [DOI: 10.4239/wjd.v13.i8.613] [Reference Citation Analysis]
4 Lok KH, Wareham NJ, Nair RS, How CW, Chuah LH. Revisiting The Concept of Incretin and Enteroendocrine L-cells as Type 2 Diabetes Mellitus Treatment. Pharmacol Res 2022;:106237. [PMID: 35487405 DOI: 10.1016/j.phrs.2022.106237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xu Y, Fourniols T, Labrak Y, Préat V, Beloqui A, des Rieux A. Surface Modification of Lipid-Based Nanoparticles. ACS Nano 2022. [PMID: 35446546 DOI: 10.1021/acsnano.2c02347] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Yang Y, Chen F, Xu N, Yao Q, Wang R, Xie X, Zhang F, He Y, Shao D, Dong W, Fan J, Sun W, Peng X. Red-light-triggered self-destructive mesoporous silica nanoparticles for cascade-amplifying chemo-photodynamic therapy favoring antitumor immune responses. Biomaterials 2022;281:121368. [DOI: 10.1016/j.biomaterials.2022.121368] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
7 Jackman MJ, Davies NM, Bak A, Puri S. Landscape for oral delivery of peptides. Oral Delivery of Therapeutic Peptides and Proteins 2022. [DOI: 10.1016/b978-0-12-821061-1.00001-0] [Reference Citation Analysis]
8 Sharma D, Gulati SS, Sharma N, Chaudhary A. Sustainable synthesis of silver nanoparticles using various biological sources and waste materials: a review. emergent mater . [DOI: 10.1007/s42247-021-00292-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Durán-Lobato M, López-Estévez AM, Cordeiro AS, Dacoba TG, Crecente-Campo J, Torres D, Alonso MJ. Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape. Adv Drug Deliv Rev 2021;176:113899. [PMID: 34314784 DOI: 10.1016/j.addr.2021.113899] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
10 Qin W, Ying W, Hamaker B, Zhang G. Slow digestion-oriented dietary strategy to sustain the secretion of GLP-1 for improved glucose homeostasis. Compr Rev Food Sci Food Saf 2021. [PMID: 34350681 DOI: 10.1111/1541-4337.12808] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
11 Cano-Cortes MV, Altea-Manzano P, Laz-Ruiz JA, Unciti-Broceta JD, Lopez-Delgado FJ, Espejo-Roman JM, Diaz-Mochon JJ, Sanchez-Martin RM. An effective polymeric nanocarrier that allows for active targeting and selective drug delivery in cell coculture systems. Nanoscale 2021;13:3500-11. [PMID: 33560282 DOI: 10.1039/d0nr07145e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Xu Y, Michalowski CB, Beloqui A. Advances in lipid carriers for drug delivery to the gastrointestinal tract. Current Opinion in Colloid & Interface Science 2021;52:101414. [DOI: 10.1016/j.cocis.2020.101414] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
13 Eissa NG, Elsabahy M, Allam A. Engineering of smart nanoconstructs for delivery of glucagon-like peptide-1 analogs. Int J Pharm 2021;597:120317. [PMID: 33540005 DOI: 10.1016/j.ijpharm.2021.120317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Dubey SK, Parab S, Dabholkar N, Agrawal M, Singhvi G, Alexander A, Bapat RA, Kesharwani P. Oral peptide delivery: challenges and the way ahead. Drug Discov Today 2021;26:931-50. [PMID: 33444788 DOI: 10.1016/j.drudis.2021.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
15 Wang Y, Wang C, Li K, Song X, Yan X, Yu L, He Z. Recent advances of nanomedicine-based strategies in diabetes and complications management: Diagnostics, monitoring, and therapeutics. J Control Release 2021;330:618-40. [PMID: 33417985 DOI: 10.1016/j.jconrel.2021.01.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
16 Arévalo-pérez R, Maderuelo C, Lanao JM. Recent advances in colon drug delivery systems. Journal of Controlled Release 2020;327:703-24. [DOI: 10.1016/j.jconrel.2020.09.026] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 9.7] [Reference Citation Analysis]
17 Kanugo A, Misra A. New and novel approaches for enhancing the oral absorption and bioavailability of protein and peptides therapeutics. Therapeutic Delivery 2020;11:713-32. [DOI: 10.4155/tde-2020-0068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Tong T, Wang L, You X, Wu J. Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability. Biomater Sci 2020;8:5804-23. [PMID: 33016274 DOI: 10.1039/d0bm01151g] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]